Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Frodl

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Pharmacopsychiatry|September 3, 2008
Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET studyE M Meisenzahl, G Schmitt, G Gründer, et al.
Genes, Brain, and Behavior|April 5, 2008
5-HT1A receptor gene C -1019 G polymorphism and amygdala volume in borderline personality disorderT Zetzsche, U W Preuss, B Bondy, et al.
Schizophrenia Research|August 16, 2008
Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric studyE M Meisenzahl, N Koutsouleris, R Bottlender, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 8, 2006
Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigationE M Meisenzahl, J Scheuerecker, M Zipse, et al.
Molecular Psychiatry|November 15, 2008
Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depressionT Frodl, N Koutsouleris, R Bottlender, et al.
Journal of Affective Disorders|February 5, 2021
Real-world evidence from a European cohort study of patients with treatment resistant depression: Baseline patient characteristicsK Heerlein, A H Young, C Otte, et al.
Journal of Affective Disorders|May 27, 2021
Real-world evidence from a European cohort study of patients with treatment resistant depression: Treatment patterns and clinical outcomesK Heerlein, G Perugi, C Otte, et al.
Journal of Affective Disorders|November 7, 2021
Real-world evidence from a European cohort study of patients with treatment resistant depression: Healthcare resource utilizationK Heerlein, S De Giorgi, G Degraeve, et al.
Molecular Psychiatry|May 25, 2016
Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysisT Wise, J Radua, E Via, et al.
Molecular Psychiatry|February 24, 2016
Response to Dr Fried & Dr Kievit, and Dr Malhi et alL Schmaal, D J Veltman, T G M van Erp, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Pharmacopsychiatry|September 3, 2008
Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET studyE M Meisenzahl, G Schmitt, G Gründer, et al.
Genes, Brain, and Behavior|April 5, 2008
5-HT1A receptor gene C -1019 G polymorphism and amygdala volume in borderline personality disorderT Zetzsche, U W Preuss, B Bondy, et al.
Schizophrenia Research|August 16, 2008
Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric studyE M Meisenzahl, N Koutsouleris, R Bottlender, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 8, 2006
Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigationE M Meisenzahl, J Scheuerecker, M Zipse, et al.
Molecular Psychiatry|November 15, 2008
Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depressionT Frodl, N Koutsouleris, R Bottlender, et al.
Journal of Affective Disorders|February 5, 2021
Real-world evidence from a European cohort study of patients with treatment resistant depression: Baseline patient characteristicsK Heerlein, A H Young, C Otte, et al.
Journal of Affective Disorders|May 27, 2021
Real-world evidence from a European cohort study of patients with treatment resistant depression: Treatment patterns and clinical outcomesK Heerlein, G Perugi, C Otte, et al.
Journal of Affective Disorders|November 7, 2021
Real-world evidence from a European cohort study of patients with treatment resistant depression: Healthcare resource utilizationK Heerlein, S De Giorgi, G Degraeve, et al.
Molecular Psychiatry|May 25, 2016
Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysisT Wise, J Radua, E Via, et al.
Molecular Psychiatry|February 24, 2016
Response to Dr Fried & Dr Kievit, and Dr Malhi et alL Schmaal, D J Veltman, T G M van Erp, et al.
Pageof 6